Anticardiolipin (aCL) antibodies in a patient with Behçet's syndrome with vena cava inferior thrombosis

D G Ebo; P G Bracke; L S De Clerck; L M Francx; W J Stevens

doi:10.1007/BF02238771

Anticardiolipin (aCL) antibodies in a patient with Behçet's syndrome with vena cava inferior thrombosis

Clin Rheumatol. 1997 Jan;16(1):96-8. doi: 10.1007/BF02238771.

Authors

D G Ebo¹, P G Bracke, L S De Clerck, L M Francx, W J Stevens

Affiliation

¹ Department of Immunology-Allergology-Rheumatology, University of Antwerp.

PMID: 9132335
DOI: 10.1007/BF02238771

Abstract

This case report describes a patient with Behçet's syndrome with sustained anticardiolipin antibodies presenting a vena cava inferior thrombosis in a period of anabolic steroid use. The vascular manifestations and occurrence of antiphospholipid antibodies in Behçet's syndrome are reviewed. The possible thrombogenicity of anabolic steroids is reemphasized.

Publication types

Case Reports
Review

MeSH terms

Anabolic Agents / administration & dosage
Anabolic Agents / adverse effects*
Anabolic Agents / therapeutic use
Antibodies, Anticardiolipin / analysis
Antibodies, Anticardiolipin / blood*
Behcet Syndrome / complications*
Behcet Syndrome / drug therapy
Behcet Syndrome / immunology
Cerebral Infarction / complications*
Cerebral Infarction / diagnostic imaging
Cerebral Infarction / immunology
Enzyme-Linked Immunosorbent Assay
Humans
Injections, Intramuscular
Male
Stanozolol / administration & dosage
Stanozolol / adverse effects*
Stanozolol / therapeutic use
Thrombosis / chemically induced*
Thrombosis / diagnostic imaging
Thrombosis / immunology
Ultrasonography, Doppler
Vena Cava, Inferior*

Substances

Anabolic Agents
Antibodies, Anticardiolipin
Stanozolol